News Announcement

Solara Active Pharma Sciences: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

Pursuant to Regulation 30 and 46 read with clause 15 of Para A of Part A of Schedule Ill of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby confirm that we have uploaded audio recording of the Q4 of FY23 Earnings Call held on May 12 2023 on our Company website under the heading Investor relations/Stock Exchange Communication/ Investor update.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.